Literature DB >> 10430232

Relative excess risk: an alternative measure of comparative risk.

S Suissa1.   

Abstract

The proverbial relative risk may not always be the most suitable measure to compare the risk of two exposures, since it inherently includes a background effect. An alternative comparative measure, the relative excess risk, is introduced. It applies to situations in which an "unexposed" reference group is included in addition to the two exposures under evaluation. This comparative measure is based solely on the component of risk due to the exposures, since it removes the background risk. Estimators of the relative excess risk are presented, along with formulas for the confidence intervals under cohort and case-control designs, using both crude and adjusted rate ratios. This new measure is illustrated with data from epidemiologic studies of the risks of oral contraceptives and antidiabetic drugs.

Mesh:

Substances:

Year:  1999        PMID: 10430232     DOI: 10.1093/oxfordjournals.aje.a009999

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Drug interactions avoided-a useful indicator of good prescribing practice.

Authors:  D Williams; A Kelly; J Feely
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  The Impact of Improved Population Life Expectancy in Survival Trend Analyses of Specific Diseases.

Authors:  Carl van Walraven
Journal:  Health Serv Res       Date:  2015-10-20       Impact factor: 3.402

3.  Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison.

Authors:  Nina C A Vermeer; Yvette H M Claassen; Marloes G M Derks; Lene H Iversen; Elizabeth van Eycken; Marianne G Guren; Pawel Mroczkowski; Anna Martling; Robert Johansson; Tamara Vandendael; Arne Wibe; Bjorn Moller; Hans Lippert; Johanneke E A Portielje; Gerrit Jan Liefers; Koen C M J Peeters; Cornelis J H van de Velde; Esther Bastiaannet
Journal:  Oncologist       Date:  2018-03-22

4.  Differential Mortality Risks Associated With PM2.5 Components: A Multi-Country, Multi-City Study.

Authors:  Pierre Masselot; Francesco Sera; Rochelle Schneider; Haidong Kan; Éric Lavigne; Massimo Stafoggia; Aurelio Tobias; Hong Chen; Richard T Burnett; Joel Schwartz; Antonella Zanobetti; Michelle L Bell; Bing-Yu Chen; Yue-Liang Leon Guo; Martina S Ragettli; Ana Maria Vicedo-Cabrera; Christofer Åström; Bertil Forsberg; Carmen Íñiguez; Rebecca M Garland; Noah Scovronick; Joana Madureira; Baltazar Nunes; César De la Cruz Valencia; Magali Hurtado Diaz; Yasushi Honda; Masahiro Hashizume; Chris Fook Cheng Ng; Evangelia Samoli; Klea Katsouyanni; Alexandra Schneider; Susanne Breitner; Niilo R I Ryti; Jouni J K Jaakkola; Marek Maasikmets; Hans Orru; Yuming Guo; Nicolás Valdés Ortega; Patricia Matus Correa; Shilu Tong; Antonio Gasparrini
Journal:  Epidemiology       Date:  2022-03-01       Impact factor: 4.860

5.  Population-level trends in relative survival for cervical cancer.

Authors:  Jason D Wright; Ling Chen; Ana I Tergas; William M Burke; June Y Hou; Alfred I Neugut; Cande V Ananth; Dawn L Hershman
Journal:  Am J Obstet Gynecol       Date:  2015-07-23       Impact factor: 8.661

6.  Trends in 1-year survival of people admitted to hospital in Ontario, 1994-2009.

Authors:  Carl van Walraven
Journal:  CMAJ       Date:  2013-09-30       Impact factor: 8.262

7.  Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009.

Authors:  Kyu-Won Jung; Sohee Park; Aesun Shin; Chang-Mo Oh; Hyun-Joo Kong; Jae Kwan Jun; Young-Joo Won
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

8.  Excess relative risk as an effect measure in case-control studies of rare diseases.

Authors:  Wen-Chung Lee
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

9.  Breast cancer survival in Germany: a population-based high resolution study from Saarland.

Authors:  Bernd Holleczek; Lina Jansen; Hermann Brenner
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

10.  Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.

Authors:  Bernd Holleczek; Hermann Brenner
Journal:  BMC Cancer       Date:  2014-10-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.